Lexicon to disband sales team, lay off 60% of staff | BioPharma Dive

Quote

anonymous

Guest
Lexicon to disband sales team, lay off 60% of staff | BioPharma Dive

https://www.biopharmadive.com/news/lexicon-layoffs-restructuring-zynquista-deficiencies-fda/733712/


Dive Brief:​

  • Lexicon Pharmaceuticals will lay off 60% of its workforce and eliminate its commercial organization in a restructuring meant to save $100 million in operating costs next year.
  • The shakeup follows Lexicon’s receipt of a letter from the Food and Drug Administration that cited “deficiencies” in the company’s approval application for its diabetes drug Zynquista. The therapy has been under review by the agency, which was aiming to reach a decision by Dec. 20.
  • Lexicon will now pivot to focus on its research pipeline, which includes a drug in Phase 2 testing for diabetic peripheral neuropathic pain and a preclinical obesity therapy. The company is also testing sotagliflozin, the active ingredient of Zynquista, in a Phase 3 study of people with hypertrophic cardiomyopathy.
 












Unfair comment. This place was never meant to be a commercial organization. Leave your continued racist-bating commentary behind. Yes, you “ghetto pharma“ person! Your comments are stale and from another age. This place sucked and it took on some people that it didn’t need, but it can succeed.
 












This 3 year experiment was not only a waste of time and investor dollars, but it caused serious and damaging career disruption for many people. Many were convinced by leadership who hired people away, in some cases, from stable jobs and careers. I’ve spoken with managers who feel guilty for painting this outhouse of a company as anything other than a poorly planned foray into the commercial abyss about which they knew nothing. People were outright harassed and leaned on when the numbers weren’t coming in. And it wasn’t just about formulary access. The top of the medical chain smoothly sold everyone a bill of clinical goods that provided little to no differentiation. Refocusing the company‘s efforts should only happen after a complete overhaul of each area.
 






This really all leads back to Coats. He had essentially no experience successfully launching products and zero experience handling clinical programs. Eisai US (where he came from) basically existed to manage co-promotes with two large partners who did at least 90% of the work.
 






anonymous said:
This really all leads back to Coats. He had essentially no experience successfully launching products and zero experience handling clinical programs. Eisai US (where he came from) basically existed to manage co-promotes with two large partners who did at least 90% of the work.
Click to expand...
Affirmative action is a wonderful thing.
 






are you surprised about the sales team? Launch strategy was poor and lets not even go there when it comes to managed care coverage.

I feel for the people who took jobs there, some leaving good situations for what turned out to be a disaster.
 












anonymous said:
are you surprised about the sales team? Launch strategy was poor and lets not even go there when it comes to managed care coverage.

I feel for the people who took jobs there, some leaving good situations for what turned out to be a disaster.
Click to expand...
Complete disaster all the way around. Many people were hurt. This all goes back to the inept, failed so-called leadership team with Coats at the top.
 






anonymous said:
are you surprised about the sales team? Launch strategy was poor and lets not even go there when it comes to managed care coverage.

I feel for the people who took jobs there, some leaving good situations for what turned out to be a disaster.
Click to expand...
Called off my interview back when they were building a salesforce, when the manager told me they were going to blow Jardiance and Farxiga out of the water with their T1D indication. Asked him what managed care coverage they would have. He said they won’t need it when the doctors see T1D and T2D indications. I argued for a minute then said thanks, no thanks! Great decision on my part.
 






anonymous said:
Called off my interview back when they were building a salesforce, when the manager told me they were going to blow Jardiance and Farxiga out of the water with their T1D indication. Asked him what managed care coverage they would have. He said they won’t need it when the doctors see T1D and T2D indications. I argued for a minute then said thanks, no thanks! Great decision on my part.
Click to expand...
These clowns were so out of their depth it’s not even funny.
 




































anonymous said:
well you got all the DEI hires aaron, sluby and TW who knows squat so what do you expect! they only know how these even became managers in the first place
Click to expand...
While many white women have made gains in American workplaces, the gains for racial and ethnic minority women haven't been as significant. According to another McKinsey study, white women hold nearly 19% of all C-suite positions, while racial and ethnic minority women only hold 4%. Overall, white women have benefited disproportionally from corporate DEI efforts.
 






anonymous said:
While many white women have made gains in American workplaces, the gains for racial and ethnic minority women haven't been as significant. According to another McKinsey study, white women hold nearly 19% of all C-suite positions, while racial and ethnic minority women only hold 4%. Overall, white women have benefited disproportionally from corporate DEI efforts.
Click to expand...
Did you figure racial population percentages into this high level analysis?
 






anonymous said:
Did you figure racial population percentages into this high level analysis?
Click to expand...
Contrary to popular belief, Blacks are not the only, or even the primary beneficiaries of affirmative action. According to the United States Labor Department, the primary beneficiar- ies of affirmative action are white women.
 






Top Bottom
Back
Quote